
QIAGEN N.V. QGEN
Annual report 2025
added 04-18-2026
QIAGEN N.V. Operating Cash Flow 2011-2026 | QGEN
Annual Operating Cash Flow QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 654 M | 674 M | 459 M | 715 M | 639 M | 458 M | 331 M | 359 M | 287 M | 342 M | 317 M | 288 M | 259 M | 245 M | 245 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 715 M | 245 M | 418 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
-102 M | $ 18.24 | 1.9 % | $ 561 M | ||
|
Guardant Health
GH
|
-185 M | $ 133.22 | 4.48 % | $ 16.7 B | ||
|
ICON Public Limited Company
ICLR
|
1.04 B | $ 136.8 | 15.49 % | $ 10.7 B | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 1.8 | - | $ 7.96 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 135.38 | 16.87 % | $ 41.2 B | ||
|
Celcuity
CELC
|
-153 M | $ 130.91 | -2.28 % | $ 6.12 B | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 11.19 | 53.29 % | $ 14.9 M | ||
|
Castle Biosciences
CSTL
|
64.3 M | $ 22.11 | 4.0 % | $ 641 M | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-24.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
42 M | $ 22.7 | 2.44 % | $ 1.21 B | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
837 M | $ 158.7 | 5.68 % | $ 25.2 B | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 99.62 | 0.53 % | $ 6.72 B | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-9.68 M | - | - | $ 7.1 B | ||
|
Mettler-Toledo International
MTD
|
956 M | $ 1 163.5 | 6.31 % | $ 24 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
5.23 M | $ 10.19 | 6.48 % | $ 1.31 B | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
26.4 M | $ 19.66 | 2.77 % | $ 440 M | ||
|
Natera
NTRA
|
-432 M | $ 213.94 | 5.33 % | $ 21.1 B | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 181.34 | 10.24 % | $ 8.99 B | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
713 M | $ 448.12 | 4.7 % | $ 12.9 B | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 4.22 | 7.38 % | $ 391 M | ||
|
Personalis
PSNL
|
-74.9 M | $ 10.98 | 15.7 % | $ 980 M | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 6.72 | 6.33 % | $ 280 M | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.43 | -1.02 % | $ 5.58 M | ||
|
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 69.03 | 7.57 % | $ 4.13 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 262.75 | 1.73 % | $ 21.9 B | ||
|
Thermo Fisher Scientific
TMO
|
7.82 B | $ 487.22 | 6.75 % | $ 184 B | ||
|
Waters Corporation
WAT
|
653 M | $ 366.67 | 7.13 % | $ 21.8 B | ||
|
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.7 | 3.56 % | $ 251 M | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 9.3 | 1.09 % | $ 2.02 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 196.2 | 1.07 % | $ 21.8 B |